vastarel
ist.farm.biol.stroder s.r.l. - trimetazidina - trimetazidina
surmontil
sanofi s.r.l. - trimipramina - trimipramina
triherpine
medivis s.r.l. - trifluridina - trifluridina
lonsurf
les laboratoires servier - trifluridina, tipiracil hydrochloride - neoplasie colorettali - agenti antineoplastici - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
vastarel
gmm farma s.r.l. - trimetazidina - trimetazidina
lonsurf 15 mg/6.14 mg compresse rivestite con film
servier (suisse) sa - trifluridinum, tipiracilum - compresse rivestite con film - trifluridinum 15 mg, tipiracilum 6.14 mg ut tipiracili hydrochloridum, lactosum monohydricum 90.735 mg, amylum pregelificatum, acidum stearicum, pellicule: hypromellosum, macrogolum 8000, e 171, magnesii stearas, encre: lacca, e 172 (rubrum), e 172 (flavum), e 171, e 132, cera carnauba, talcum, pro compresso obducto. - cancer colorectal métastatique, cancer gastrique métastatique - synthetika
lonsurf 20 mg/8.19 mg compresse rivestite con film
servier (suisse) sa - trifluridinum, tipiracilum - compresse rivestite con film - trifluridinum 20 mg, tipiracilum 8.19 mg ut tipiracili hydrochloridum, lactosum monohydricum 120.980 mg, amylum pregelificatum, acidum stearicum, pellicule: hypromellosum, macrogolum 8000, e 171, e 172 (rubrum), magnesii stearas, encre: lacca, e 172 (rubrum), e 172 (flavum), e 171, e 132, cera carnauba, talcum, pro compresso obducto. - cancer colorectal métastatique, cancer gastrique métastatique - synthetika
surmontil 25 mg compresse
neuraxpharm switzerland ag - trimipraminum - compresse - trimipraminum 25 mg a trimipramini malea, excipiens pro compresso. - antidepressivo - synthetika
surmontil 100 mg compresse
neuraxpharm switzerland ag - trimipraminum - compresse - trimipraminum 100 mg a trimipramini malea, excipiens pro compresso. - antidepressivo - synthetika
surmontil gocce
neuraxpharm switzerland ag - trimipraminum - gocce - trimipraminum 40 mg a trimipramini mesilas, arom.: ethylvanillinum, vanillinum e di altro colore.: e 150a, excipiens per soluzione pro 1 ml corrisp. 40 gocce corrisp. ethanolum 11 % v/v. - antidepressivo - synthetika